Granulomatous Pneumonia

Granulomatous pneumonia is a chronic inflammatory condition of the lungs characterized by the formation of granulomas, which are organized clusters of immune cells that wall off persistent infectious agents or foreign materials that the body cannot eliminate. In reptiles, this type of pneumonia represents a particularly challenging condition to treat because the granulomatous response, while protective in containing pathogens, also creates physical barriers that prevent antibiotics and antifungal medications from reaching the organisms they need to kill. This results in chronic, persistent infection that requires prolonged treatment and may never fully resolve.

This condition affects all reptile species and can result from various underlying causes including mycobacterial infections, chronic fungal infections, foreign body reactions, and persistent bacterial infections that the immune system cannot clear. Unlike acute bacterial pneumonia that may respond relatively quickly to appropriate therapy, granulomatous pneumonia develops over time and tends to progress slowly but persistently. The condition is often discovered incidentally during radiographic examination for other problems, or may present as gradual decline in body condition and subtle respiratory symptoms that develop over weeks to months.

The impact of granulomatous pneumonia on reptile health can be severe despite the often subtle presentation. Granulomas occupy lung space and reduce functional respiratory capacity, potentially causing chronic hypoxia and reduced exercise tolerance. The chronic inflammatory state demands metabolic resources that can lead to weight loss and muscle wasting even when appetite remains present. Additionally, some organisms that cause granulomatous pneumonia, particularly mycobacteria, carry zoonotic potential, making accurate diagnosis important for both the reptile's treatment and the owner's safety.

Treatment of granulomatous pneumonia requires identification of the underlying cause when possible, as therapeutic approaches differ significantly depending on whether the granulomas contain bacteria, mycobacteria, fungi, or other agents. Even with accurate diagnosis and appropriate therapy, treatment typically extends for months to years, and complete cure may not be achievable in all cases. Owners must understand the chronic nature of this condition and the commitment required for management. A reptile-experienced veterinarian with access to advanced diagnostics is essential for accurate diagnosis and treatment planning.

The primary causes of granulomatous pneumonia in reptiles involve chronic infections with organisms that trigger granuloma formation as the immune system's method of containing pathogens it cannot eliminate. Mycobacterial infections, caused by various species of Mycobacterium, are among the most common causes of granulomatous lung disease in reptiles. These organisms are particularly problematic because they are resistant to killing by immune cells and most conventional antibiotics, leading to persistent infection that the body walls off with granulomatous tissue. Mycobacteria are found in soil and water environments and can infect reptiles through inhalation, ingestion, or wound contamination.

Fungal infections represent another major cause of granulomatous pneumonia in reptiles. Various pathogenic fungi including Aspergillus, Candida, and other species can establish pulmonary infections that trigger granulomatous responses. Reptiles are particularly susceptible to fungal infections when immune function is compromised by suboptimal temperatures, stress, or concurrent disease. Fungal spores are ubiquitous in the environment and can be inhaled, with infection establishing when immune defenses are inadequate. Chronic fungal granulomas can be extremely difficult to treat, as antifungal medications must penetrate granulomatous tissue to reach viable organisms.

Husbandry-related factors contribute significantly to granulomatous pneumonia development by creating conditions that compromise immunity and allow chronic infections to establish. Suboptimal temperatures reduce immune function and impair the reptile's ability to clear pathogens before granulomatous responses develop. Chronically inadequate humidity can damage respiratory membranes and create conditions favorable for certain pathogens. Poor sanitation allows buildup of environmental pathogens, increasing exposure and infection pressure. Chronic stress from improper enclosure setup, overcrowding, or handling suppresses immunity over time. These factors may not directly cause disease but enable opportunistic pathogens to establish the chronic infections that lead to granuloma formation.

Foreign body reactions and chronic inflammatory conditions can also cause granulomatous pneumonia in the absence of active infection. Aspirated material that is not completely cleared may trigger granuloma formation as the body attempts to wall off the foreign substance. Inhaled environmental irritants or particles, particularly in dusty enclosure conditions, may cause chronic inflammation that progresses to granulomatous changes. Previous respiratory infections that were partially treated or never fully resolved may leave residual inflammation or organisms that trigger ongoing granulomatous responses. Parasitic infections of the respiratory tract, while less common, can also cause granulomatous reactions.

The pathophysiology of granulomatous pneumonia involves the immune system's attempt to contain pathogens through organized cellular responses when acute killing mechanisms fail. When immune cells encounter organisms they cannot eliminate, they organize into structures called granulomas, with macrophages transforming into epithelioid cells and giant cells that surround the offending material. In reptiles, these granulomas often develop caseous centers, accumulating thick, cheese-like material composed of dead cells, organisms, and debris. This caseous material cannot be absorbed or liquefied like mammalian abscesses, meaning surgical removal may be required for resolution. As granulomas enlarge and multiply, they progressively reduce functional lung tissue, eventually compromising respiratory function significantly.

Early warning signs of granulomatous pneumonia are often extremely subtle because the chronic, slowly progressive nature of the condition allows reptiles to compensate over time. Gradual weight loss despite apparently normal appetite may be the first indication of chronic disease, as metabolic demands of ongoing inflammation exceed nutritional intake. Subtle decreases in activity level or exercise tolerance may be noticed by observant owners familiar with their reptile's normal behavior patterns. Slight changes in breathing pattern, particularly during activity or stress, may hint at reduced respiratory capacity. The reptile may show marginally decreased appetite or become more selective about food items. These early signs are frequently attributed to aging or other causes, delaying diagnosis.

Common visible symptoms become more apparent as granulomatous disease progresses and respiratory capacity decreases. Respiratory effort may become visible, with increased body movement during breathing that becomes more pronounced over time. Some reptiles may breathe with slightly opened mouths, particularly after exertion or when stressed. General body condition declines, with muscle wasting visible along the spine and tail base despite continued food intake. The reptile may appear less alert or interactive than normal. Coloration may become dull or altered from normal appearance. These symptoms often develop so gradually that owners may not recognize them until comparing current appearance to photographs from months earlier.

Behavioral changes associated with granulomatous pneumonia reflect both respiratory compromise and the general malaise of chronic disease. Activity level decreases progressively, with affected reptiles spending more time resting and showing less interest in exploration or interaction. Basking behavior may change, with some reptiles seeking higher temperatures to support immune function while others become too lethargic to thermoregulate effectively. Appetite may slowly decline or become inconsistent. Social behavior diminishes in species that normally interact with owners. The reptile may prefer elevated surfaces where breathing is easier or adopt unusual postures that facilitate respiration.

Physical signs of granulomatous pneumonia detected during veterinary examination or careful observation include visible wasting despite caloric intake, changes in body condition score, and respiratory abnormalities. Auscultation may reveal decreased breath sounds in areas of granulomatous involvement, or may sound relatively normal early in disease. The reptile may show slight elevation of respiratory rate or effort. Dehydration may be present, contributing to reduced skin elasticity and slightly sunken eyes. Muscle mass reduction becomes apparent on palpation. Body weight has typically declined from previous measurements, often significantly.

Symptom progression in granulomatous pneumonia follows a gradual trajectory over months to years if untreated. Respiratory difficulty slowly increases as more lung tissue becomes compromised by expanding or multiplying granulomas. Body condition continues to deteriorate as chronic inflammation drains metabolic resources. Eventually, respiratory compromise may become severe enough to cause obvious distress, open-mouth breathing, and inability to perform normal activities. Some reptiles develop secondary bacterial infections in damaged lung tissue, causing acute worsening superimposed on chronic decline. Without treatment, the condition progresses to respiratory failure, though the timeline may extend over a year or longer depending on the extent and rate of granuloma growth.

Emergency symptoms requiring immediate veterinary intervention include acute respiratory distress with open-mouth breathing and visible effort, cyanosis indicated by blue or purple discoloration of mucous membranes, collapse or inability to maintain normal posture, severe lethargy or unresponsiveness, and complete anorexia with rapid weight loss. While granulomatous pneumonia typically progresses slowly, acute complications including secondary bacterial infection, massive granuloma formation, or respiratory decompensation can create emergencies requiring immediate care. Any sudden worsening in a reptile with known or suspected granulomatous lung disease should prompt emergency veterinary evaluation.

Physical examination by a reptile-experienced veterinarian provides initial assessment but often reveals relatively subtle findings in early to moderate granulomatous pneumonia. Body condition is typically reduced, sometimes significantly, with visible muscle wasting and decreased body weight. Respiratory pattern may show slightly increased rate or effort, though this can be difficult to distinguish from stress-related changes during examination. Auscultation may reveal decreased breath sounds in affected lung regions, or may sound relatively normal if granulomas are focal or small. The oral cavity should be examined for evidence of concurrent disease. History typically reveals gradual decline over weeks to months, with subtle changes in appetite, activity, and body condition.

Diagnostic imaging is crucial for identifying and characterizing granulomatous lung disease. Radiographs reveal discrete nodular densities within lung fields, which may be single or multiple and vary in size from barely visible to large masses occupying significant lung volume. Granulomas appear as rounded, well-defined opacities that differ from the diffuse haziness of standard bacterial pneumonia. Advanced imaging with computed tomography provides detailed assessment of granuloma number, size, location, and relationship to surrounding structures, which is valuable for surgical planning. Serial imaging helps monitor disease progression or response to treatment. Radiographic findings may be discovered incidentally during examination for other problems, sometimes before clinical symptoms become apparent.

Husbandry review remains important for understanding contributing factors and planning treatment, as environmental conditions directly influence immune function and treatment success. Temperature history helps identify chronic suboptimal conditions that may have contributed to disease development. Humidity and ventilation assessment identifies conditions that might promote certain pathogens. Substrate and enclosure cleanliness affect environmental pathogen loads. History of stress, including recent changes, transport, or addition of new animals, may reveal immune-compromising factors. Understanding husbandry provides context for why chronic infection developed and guides environmental corrections necessary for treatment success.

Advanced diagnostic testing is essential for identifying the causative agent and planning appropriate therapy. Fine needle aspiration of granulomas under ultrasound guidance can provide material for cytology and culture, though yields are variable. Acid-fast staining of samples helps identify mycobacterial infections. Fungal culture identifies fungal species if present. PCR testing can detect specific pathogens including Mycobacterium species. Surgical biopsy may be necessary for definitive diagnosis when less invasive sampling fails to identify the cause. Complete blood count and blood chemistry assess overall health status and organ function. Screening for common reptile pathogens helps identify underlying infections that may contribute to immunosuppression.

Husbandry optimization is essential for supporting immune function during the prolonged treatment required for granulomatous pneumonia. Environmental temperatures should be maintained at the upper end of the species-appropriate range to maximize immune response and support the body's ability to fight chronic infection. Basking spots must reach optimal temperatures, with reliable heating equipment monitored carefully. Humidity should be appropriate for the species, supporting respiratory health without creating conditions that favor fungal growth. Enclosure cleanliness should be meticulous to reduce environmental pathogen loads. Stress reduction through appropriate hiding spots, visual barriers, and minimal handling supports immune function. These environmental factors directly influence treatment success and must be addressed alongside medical therapy.

Medical management depends entirely on the identified causative organism and presents significant challenges regardless of etiology. Mycobacterial infections require prolonged multi-drug therapy, often with medications such as clarithromycin, rifampin, and ethambutol in various combinations based on species and sensitivity testing. Treatment extends for many months, often a year or longer, with variable cure rates and significant risk of treatment failure. Fungal infections require antifungal medications such as itraconazole, voriconazole, or terbinafine, with treatment extending for months. The granulomatous encapsulation of organisms impairs drug penetration, often making medical therapy alone insufficient. Anti-inflammatory medications may help reduce granulomatous tissue and improve drug access to organisms.

Surgical intervention is often necessary for granulomatous pneumonia because medical therapy alone frequently fails to resolve encapsulated lesions. Unlike mammalian abscesses that liquefy and can drain, reptile granulomas contain caseous material that must be physically removed. Surgical access to the coelomic cavity allows direct visualization and removal of granulomas. The extent of surgery depends on granuloma number, size, and location. In some cases, partial lung resection may be necessary to remove all affected tissue. Surgery carries inherent risks, particularly in compromised patients, and must be performed by veterinarians experienced with reptile surgery. Post-surgical care requires intensive management and prolonged recovery.

Supportive care addresses the systemic effects of chronic disease and supports the reptile through prolonged treatment. Nutritional support is essential, as affected reptiles often have reduced appetite and increased metabolic demands. High-quality, easily digestible foods should be offered, with supplemental feeding if necessary to maintain body condition. Fluid therapy addresses dehydration and supports organ function. Vitamin supplementation, particularly vitamin A for epithelial health, may support recovery. Pain management should not be overlooked, as chronic disease causes discomfort. Hospitalization may be necessary for intensive care, particularly around surgical interventions. Regular monitoring allows early detection of treatment complications or failure.

Species-specific treatment considerations influence therapeutic approaches and prognosis. Larger reptiles may tolerate surgical intervention better than small species and may be more accessible for granuloma removal. Some species are more prone to particular causative organisms, which may guide empirical treatment before culture results are available. Species with particularly slow metabolism may require extended treatment courses. Aquatic species present unique challenges for medication administration and post-surgical management. Arboreal species may need modified enclosure setups during recovery. Individual factors including age, overall health, and extent of disease influence treatment decisions more than species factors in many cases.

Treatment timeline for granulomatous pneumonia extends to months or years, representing one of the longest treatment courses in reptile medicine. Even with surgical removal of visible granulomas, residual organisms may persist, requiring extended antimicrobial therapy to prevent recurrence. Treatment success is measured in months, with periodic reassessment through radiography and clinical examination. Some cases achieve apparent cure after prolonged therapy, while others are managed chronically with the goal of controlling rather than eliminating disease. Owners must understand the commitment required and the possibility that complete cure may not be achievable. Cost considerations for prolonged treatment and potential surgery should be discussed early in treatment planning.

Recovery timeline for granulomatous pneumonia is measured in months to years, with some cases never achieving complete resolution. Reptiles that respond well to treatment may show gradual improvement in body condition and activity level over several months, with radiographic evidence of granuloma reduction. Surgical cases require initial recovery from the procedure, typically two to four weeks, followed by extended medical therapy. Full recovery, if achieved, may take one to two years of consistent treatment and monitoring. Some reptiles remain on maintenance therapy indefinitely to prevent recurrence, representing chronic management rather than cure. Owners must understand this extended timeline from the beginning of treatment.

Post-treatment husbandry optimization supports ongoing recovery and prevents recurrence or new infection. Environmental conditions that contributed to disease development must be permanently corrected. Temperature gradients should be carefully maintained with reliable equipment and regular monitoring. Humidity, ventilation, and air quality should be optimized for the species. Sanitation practices should be upgraded if they contributed to disease. Stress reduction remains important even after apparent recovery, as chronic disease may leave lasting immune effects. Any animals that shared enclosure space with the affected reptile should be evaluated for subclinical infection, particularly for potentially contagious conditions like mycobacteriosis.

Prognosis for granulomatous pneumonia varies significantly based on underlying cause, extent of disease, promptness of diagnosis, and response to treatment. Cases caused by treatable bacterial or fungal infections with limited granuloma formation may have fair to good prognosis with aggressive therapy and potential surgery. Mycobacterial infections carry guarded prognosis due to the inherent resistance of these organisms to treatment and the potential for zoonotic transmission that may influence treatment decisions. Extensive granulomatous disease affecting large portions of lung tissue carries poor prognosis regardless of cause. Individual response to treatment significantly influences outcome, with some reptiles responding better than expected while others fail despite appropriate therapy.

Long-term monitoring and follow-up are essential components of granulomatous pneumonia management that continue for years after apparent resolution. Radiographic evaluation at regular intervals, often every three to six months, monitors for recurrence or new granuloma formation. Weight and body condition should be tracked closely, as declining parameters may indicate treatment failure or recurrence before radiographic changes appear. Owners should observe for any return of respiratory symptoms, decreased activity, or appetite changes. Even reptiles that achieve apparent cure warrant lifelong monitoring due to the potential for recurrence. For reptiles on maintenance therapy, regular veterinary evaluation ensures continued medication appropriateness and monitors for adverse effects of long-term treatment.

Proper husbandry setup provides the foundation for preventing granulomatous pneumonia by supporting immune function and reducing pathogen exposure. Temperature gradients must be species-appropriate and consistently maintained using reliable equipment with monitoring. Basking spots should reach optimal temperatures to support effective immune function. Humidity appropriate for the species supports respiratory health without creating conditions favorable for fungal pathogens. Ventilation provides adequate air exchange while avoiding drafts. Enclosure design should minimize stress through appropriate size, hiding spots, and visual barriers. UVB lighting for species that require it supports overall health and immune function. These environmental factors directly influence susceptibility to the chronic infections that cause granulomatous lung disease.

Dietary prevention supports overall health and immune competence through species-appropriate nutrition. Complete, balanced diets appropriate for each species provide necessary nutrients for immune function. Calcium and vitamin D3 supplementation, or adequate UVB exposure, supports overall health. Vitamin A through appropriate food items or supplementation maintains epithelial integrity including respiratory membranes. Avoiding nutritional deficiencies prevents the immune compromise that allows opportunistic infections to establish. Proper hydration supports mucus production and respiratory defense mechanisms. Obesity should be avoided, as it may compromise respiratory function and overall health.

Quarantine protocols protect established animals from potentially infected new arrivals. New reptiles should be quarantined separately for minimum sixty to ninety days with careful observation for any signs of respiratory disease or chronic illness. Veterinary examination with appropriate testing, potentially including radiographs, helps identify subclinical disease before introduction to existing animals. Mycobacterial screening should be considered for species or sources with higher risk. Animals that appear healthy but test positive for serious pathogens should not be introduced to collections of healthy animals. Wild-caught reptiles and those from unknown sources warrant extended quarantine and more intensive screening.

Regular health monitoring enables early detection of problems that could progress to chronic disease. Weight tracking reveals gradual losses that may indicate subclinical illness before other symptoms appear. Observation of breathing pattern, activity level, and appetite helps identify subtle changes. Annual or biannual veterinary examinations provide professional assessment and may include screening radiographs for valuable or at-risk animals. Fecal parasite testing identifies infections that could contribute to immunosuppression. Prompt investigation and treatment of any health abnormalities prevents progression to chronic disease states that are more difficult to treat.

Veterinary consultation provides expert guidance on disease prevention and early detection. Reptile-experienced veterinarians can advise on species-specific husbandry, nutrition, and health monitoring. Pre-purchase examinations for new acquisitions help avoid introducing disease. Wellness examinations allow early detection of subclinical problems. Understanding the causes and risk factors for granulomatous pneumonia through veterinary education helps owners take appropriate preventive measures. Establishing a relationship with a reptile veterinarian before problems develop ensures access to expertise when needed. For species or situations with particular risks, proactive screening may identify problems at early, more treatable stages.

Ongoing husbandry requirements for reptiles with history of granulomatous pneumonia or risk factors for the condition emphasize consistent optimal environmental conditions. Temperature monitoring should be continuous using reliable digital thermometers, with daily verification of basking spot and cool zone temperatures. Heating equipment should be inspected regularly and replaced proactively before failure. Humidity monitoring with hygrometers allows precise control at species-appropriate levels. Air quality benefits from adequate ventilation without drafts, appropriate substrates, and regular enclosure maintenance. For reptiles with known respiratory compromise, environmental conditions become even more critical and may require professional consultation to optimize.

Environmental management and monitoring should become systematic daily practices. Temperature and humidity checks at consistent times allow identification of trends or equipment issues. Enclosure cleaning follows regular schedules with thorough sanitation practices. Substrates are selected to minimize dust and replaced before becoming excessively contaminated. Water sources remain clean and appropriately positioned. Air filtration may benefit some setups. Equipment inspection and proactive replacement prevents failures that could compromise conditions. Documentation of environmental parameters provides valuable records for veterinary consultations and troubleshooting.

Health indicator monitoring provides early warning of problems in reptiles with chronic respiratory disease or those at risk. Daily observation of breathing pattern watches for any changes in rate, effort, or character. Weekly weighing tracks body condition with precise data that reveals trends before they become visually apparent. Appetite and food intake are recorded to identify changes. Activity level and behavior provide insight into overall wellbeing. Any deviation from established baselines warrants investigation and potentially veterinary consultation. Reptiles with known granulomatous disease require particularly close monitoring for signs of progression or recurrence.

Quality of life considerations guide ongoing care decisions for reptiles with chronic respiratory disease. Many reptiles with controlled or resolved granulomatous pneumonia can achieve good quality of life with appropriate management. Signs of acceptable quality include maintained appetite, appropriate activity level, effective thermoregulation, normal behaviors, and absence of visible distress. Reptiles that continue to decline despite optimal treatment, or those with extensive residual lung damage causing persistent distress, may not be able to achieve acceptable quality of life. These assessments should involve veterinary input and honest evaluation of the animal's daily experience.

Long-term care planning addresses the extended needs of reptiles with chronic conditions. Financial planning for ongoing veterinary care, including potential for prolonged treatment courses and repeated diagnostic imaging, helps ensure consistent care. Understanding that management may continue indefinitely for some conditions helps set realistic expectations. Documentation of health history, treatments, and responses provides valuable information for ongoing care decisions. Emergency planning includes knowing signs that warrant immediate veterinary attention. For reptiles with mycobacterial or other potentially zoonotic infections, understanding and implementing appropriate biosecurity measures protects human family members. Succession planning for long-lived species with chronic conditions ensures continued appropriate care throughout their lifespan.

High-risk species for granulomatous pneumonia include reptiles commonly exposed to environmental pathogens that cause this condition and those frequently maintained in suboptimal conditions that compromise immunity. Tortoises face particular risk for mycobacterial infections, with Mycobacterium species being significant pathogens in various tortoise species. Aquatic turtles are exposed to environmental mycobacteria and other pathogens in their aquatic environment. Bearded dragons and other commonly kept lizards may develop granulomatous lung disease when chronic infections are not effectively treated. Any reptile species can develop this condition given appropriate exposure and immune compromise, but those with particular environmental exposures or common husbandry deficiencies face elevated risk.

Captive versus wild-caught considerations significantly influence susceptibility to chronic respiratory diseases including granulomatous pneumonia. Wild-caught reptiles may harbor subclinical infections with mycobacteria or other pathogens acquired in their natural environment. Stress of capture and transport, combined with suboptimal conditions during the import chain, can allow these latent infections to progress. Parasitic burdens common in wild-caught animals compromise immunity and may predispose to secondary infections. Long-term captive-bred reptiles from reputable sources generally have lower exposure to environmental pathogens and less immunocompromising stress history. However, even captive-bred animals can develop granulomatous pneumonia if exposed to pathogens and maintained in conditions that impair immune function.

Species-specific susceptibilities relate to natural history, common husbandry challenges, and exposure patterns. Species from environments where mycobacteria are prevalent may have higher baseline exposure and potentially some adapted tolerance, or may be particularly susceptible when kept in captive conditions different from their natural habitat. Tortoises appear particularly vulnerable to mycobacterial disease. Species commonly kept in overcrowded retail or breeding situations may face increased pathogen exposure. Those with particularly demanding husbandry requirements, where conditions are frequently suboptimal, have immune compromise that predisposes to chronic infection. Individual factors including age, concurrent disease, and specific environmental history significantly influence risk within any species.

Commonly co-occurring conditions with granulomatous pneumonia often include the underlying factors that allowed chronic infection to establish. Systemic mycobacteriosis may involve multiple organs beyond the lungs, with granulomas in liver, spleen, and other tissues. Concurrent parasitic infections may have contributed to immunosuppression that allowed primary infection. Nutritional deficiencies, particularly vitamin A deficiency affecting epithelial tissues, may underlie susceptibility to respiratory infection. Other chronic infections may be present. Upper respiratory infections may coexist with lower respiratory granulomatous disease. Metabolic bone disease may indicate the husbandry deficiencies that also predisposed to respiratory infection. Comprehensive evaluation for concurrent conditions is important for successful management.

Conditions with similar symptoms to granulomatous pneumonia require differentiation for appropriate treatment planning. Lung tumors can appear similar radiographically and cause comparable clinical signs, requiring biopsy for differentiation. Acute bacterial pneumonia presents with respiratory symptoms but typically has more acute onset and diffuse rather than nodular radiographic appearance. Lung abscesses may appear similar but often have different characteristics on imaging. Fungal pneumonia without granulomatous response may appear differently on imaging. Non-infectious granulomas from foreign body reactions or other causes require histopathology for differentiation from infectious granulomas. Thorough diagnostic workup is essential for accurate diagnosis.

Secondary complications of granulomatous pneumonia can significantly affect prognosis and management. Secondary bacterial pneumonia may develop in damaged lung tissue, causing acute worsening superimposed on chronic disease. Respiratory failure from progressive loss of functional lung tissue represents the ultimate consequence of untreated disease. Systemic spread of infection, particularly with mycobacteria, can affect multiple organs. Chronic weight loss and muscle wasting compromise overall health and recovery potential. For some causative organisms, particularly mycobacteria, zoonotic transmission potential exists and must be considered in management decisions. Quality of life deterioration occurs as respiratory function progressively declines, potentially leading to humane euthanasia decisions.